Lung cancer stem cell markers as therapeutic targets: An update on signaling pathways and therapies
Open accessAbstract
Cancer stem cells, a relatively small group of self-renewing cancer cells, were first isolated from acute myeloid leukemia. These cells can play a crucial role in tumor metastasis, relapse, and therapy resistance. The cancer stem cell theory may be applied to lung cancer and explain the inefficiency of traditional treatments and eventual recurrence. However, because of the unclear accuracy and illusive biological function of cancer stem cells, some researchers remain cautious about this theory. Despite the ongoing controversy, cancer stem cells are still being investigated, and their biomarkers are being discovered for application in cancer diagnosis, targeted therapy, and prognosis prediction. Potential lung cancer stem cell markers mainly include surface biomarkers such as CD44, CD133, epithelial cell adhesion molecule, and ATP-binding cassette subfamily G member 2, along with intracellular biomarkers such as aldehyde dehydrogenase, sex-determining region Y-box 2, NANOG, and octamer-binding transcription factor 4. These markers have different structures and functions but are closely associated with the stem potential and uncontrollable proliferation of tumor cells. The aberrant activation of major signaling pathways, such as Notch, Hedgehog, and Wnt, may be associated with the expression and regulation of certain lung cancer stem cell markers, thus leading to lung cancer stem cell maintenance, chemotherapy resistance, and cancer promotion. Treatments targeting lung cancer stem cell markers, including antibody drugs, nanoparticle drugs, chimeric antigen receptor T-cell therapy, and other natural or synthetic specific inhibitors, may provide new hope for patients who are resistant to conventional lung cancer therapies. This review provides comprehensive and updated data on lung cancer stem cell markers with regard to their structures, functions, signaling pathways, and promising therapeutic target approaches, aiming to elucidate potential new therapies for lung cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cancer Stem Cells (CSCs) belong to a group of tumor cells with multidirectional differentiation capacity, high self-renewal potential, and tumorigenicity.
“Cancer Stem Cells (CSCs) belong to a group of tumor cells with a multidirectional differentiation capacity, high self-renewal potential, and tumorigenicity [51].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [51]
20E treatment at doses of 0.1-100 μM significantly inhibited the expression of all CSC markers studied (ALDH, CD44, Oct4, c-Kit, Nestin).
“Figure 10 demonstrates that 20E treatment at doses of 0.1–100 µM significantly inhibited the expression of all of the CSC markers studied.”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Taromi, S., Firat, E., Simonis, A., Braun, L. M., Apostolova, P., Elze, M., Passlick, B., Schumacher, A., Lagies, S., Frey, A., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.012 · Cited by 8 · see citing works
RetractedThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,679 · see citing works
Bonnet, D., & Dick, J. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,417 · see citing works
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · see citing works
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342 · see citing works
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J., & Lindeman, G. (2008) · Nature Reviews. Cancer · doi:10.1038/nrc2499 · Cited by 3,562 · see citing works
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487 · see citing works
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X. L., Fernandez‐Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,325 · see citing works
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyák, K. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3261 · Cited by 2,003 · see citing works
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098 · see citing works
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082 · see citing works
Clara, J., Monge, C., Yang, Y., & Takebe, N. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752 · see citing works
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749 · see citing works
Weigmann, A., Corbeil, D., Hellwig, A., & Huttner, W. Β. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12425 · Cited by 601 · see citing works
Goldstein, L. A., Zhou, D., Picker, L. J., Minty, C., Bargatze, R. F., Ding, J., & Butcher, E. C. (1989) · Cell · doi:10.1016/0092-8674(89)90639-9 · Cited by 556 · see citing works
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
Lim, J. S., Ibaseta, A., Fischer, M. M., Cancilla, B., O’Young, G., Cristea, S., Luca, V. C., Yang, D., Jahchan, N. S., Hamard, C., et al. (2017) · Nature · doi:10.1038/nature22323 · Cited by 482 · see citing works
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466 · cited 1× · see citing works
“The Wnt signaling pathway can regulate cell differentiation and proliferation, and is important in carcinogenesis, invasion, progression, and CSC maintenance (79).”
BackgroundStructure of the human multidrug transporter ABCG2
Taylor, N. M. I., Manolaridis, I., Jackson, S. M., Kowal, J., Stahlberg, H., & Locher, K. P. (2017) · Nature · doi:10.1038/nature22345 · Cited by 418 · see citing works
Sullivan, J. P., Spinola, M., Dodge, M. E., Raso, M. G., Behrens, C., Gao, B., Schuster, K., Shao, C., Larsen, J. E., Sullivan, L. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0881 · Cited by 416 · see citing works
Notch signaling controls the balance of ciliated and secretory cell fates in developing airways
Tsao, P., Vasconcelos, M., Izvolsky, K. I., Qian, J., Lü, J., & Cardoso, W. V. (2009) · Development · doi:10.1242/dev.034884 · Cited by 374 · see citing works
Clinical and Therapeutic Implications of Cancer Stem Cells
Clarke, M. F. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1804280 · Cited by 355 · see citing works
Bourguignon, L. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.007 · Cited by 305 · see citing works
Justilien, V., Walsh, M. P., Ali, S. A., Thompson, E. A., Murray, N. R., & Fields, A. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.008 · Cited by 296 · see citing works
Targeting Notch in oncology: the path forward
Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 274 · see citing works
The cancer stem cell niche—there goes the neighborhood?
Cabarcas‐Petroski, S., Mathews, L., & Farrar, W. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26312 · Cited by 264 · see citing works
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
Teng, Y., Wang, X., Wang, Y., & Ma, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.028 · Cited by 252 · see citing works
Ferone, G., Song, J., Sutherland, K. D., Bhaskaran, R., Monkhorst, K., Lambooij, J.-P., Proost, N., Gargiulo, G., & Berns, A. J. M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.001 · Cited by 244 · see citing works
All purpose Sox: The many roles of Sox proteins in gene expression
Wegner, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.006 · Cited by 231 · see citing works
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
Pietanza, M. C., Byers, L. A., Minna, J. D., & Rudin, C. M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2958 · Cited by 228 · see citing works
Jen, J., Tang, Y.-A., Lu, Y.-H., Lin, C.-C., Lai, W., & Wang, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0674-z · Cited by 219 · see citing works
Self-citationLiu, Y., Yang, C., Huang, M.-S., Yeh, C., Wu, A. T. H., Lee, Y., Lai, T., Lee, C.-H., Hsiao, Y.-W., Lu, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1733 · Cited by 210 · see citing works
Morimoto, M., Nishinakamura, R., Saga, Y., & Kopan, R. (2012) · Development · doi:10.1242/dev.083840 · Cited by 209 · see citing works
Molecular genetics and targeted therapy of WNT-related human diseases (Review)
Katoh, M., & Katoh, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3071 · Cited by 208 · see citing works
Drilon, A. E. D. C., Rekhtman, N., Ladanyi, M., & Paik, P. K. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70291-7 · Cited by 205 · see citing works
Role of OCT4 in cancer stem-like cells and chemotherapy resistance
Mohiuddin, I. S., Wei, S., & Kang, M. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.005 · Cited by 196 · see citing works
Precision medicine for human cancers with Notch signaling dysregulation (Review)
Katoh, M., & Katoh, M. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4418 · Cited by 196 · see citing works
Revisiting the hallmarks of cancer: The role of hyaluronan
Caon, I., Bartolini, B., Parnigoni, A., Caravà, E., Moretto, P., Viola, M., Karousou, E. G., Vigetti, D., & Passi, A. G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.007 · Cited by 178 · see citing works
Wang, K., Ji, W., Yu, Y., Li, Z., Niu, X., Xia, W., & Lü, S. (2018) · Oncogene · doi:10.1038/s41388-018-0311-3 · Cited by 168 · see citing works
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers
Kong, T., Ahn, R., Yang, K., Zhu, X., Fu, Z., Morin, G., Bramley, R., Cliffe, N. C., Xue, Y., Kuasne, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1108 · Cited by 161 · see citing works
The Role of Notch Receptors in Transcriptional Regulation
Wang, H., Zang, C., Liu, X. S., & Aster, J. C. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24872 · Cited by 155 · see citing works
Shah, N., Mohammad, A. S., Saralkar, P. A., Sprowls, S. A., Vickers, S. D., John, D. Q., Tallman, R. M., Lucke-Wold, B. P., Jarrell, K. L., Pinti, M. V., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.021 · Cited by 149 · see citing works
Alibolandi, M., Ramezani, M., Abnous, K., Sadeghi, F., Atyabi, F., Asouri, M., Ahmadi, A. A., & Hadizadeh, F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.026 · Cited by 147 · see citing works
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 134 · see citing works
Szala, S., Kasai, Y., Steplewski, Z., Rodeck, U., Koprowski, H., & Linnenbach, A. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6833 · Cited by 133 · see citing works
Conditional Stabilization ofβ-Catenin Expands the Pool of Lung Stem Cells
Reynolds, S. D., Zemke, A. C., Giangreco, A., Brockway, B., Teisanu, R. M., Drake, J. A., Mariani, T. J., Di, Y. P., Taketo, M. M., & Stripp, B. R. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0053 · Cited by 132 · see citing works
Potential mechanisms of CD133 in cancer stem cells
Jang, J.-W., Song, Y., Kim, S.-H., Kim, J., & Seo, H. R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.008 · Cited by 122 · see citing works
Zhang, K., Hong, X., Song, Z., Xu, Y., Li, C., Wang, G., Zhang, Y., Zhao, X., Zhao, Z., Zhao, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3976 · Cited by 120 · see citing works
Multidrug efflux transporter ABCG2: expression and regulation
Kukal, S., Guin, D., Rawat, C., Bora, S., Mishra, M., Sharma, P., Paul, P. R., Kanojia, N., Grewal, G. K., Kukreti, S., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03901-y · Cited by 119 · see citing works
Orian‐Rousseau, V., & Sleeman, J. P. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00009-5 · Cited by 115 · see citing works
Bora-Singhal, N., Perumal, D., Nguyen, J. V., & Chellappan, S. (2015) · Neoplasia · doi:10.1016/j.neo.2015.07.001 · Cited by 110 · see citing works
Zhang, Y., Xu, W., Guo, H., Zhang, Y., He, Y., Lee, S. H., Song, X., Li, X., Guo, Y., Zhao, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1633 · Cited by 104 · see citing works
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
Tripathi, S. C., Fahrmann, J. F., Çeliktaş, M., Aguilar, M., Marini, K. D., Jolly, M. K., Katayama, H., Wang, H., Murage, E. N., Dennison, J. B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2874 · Cited by 103 · see citing works
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas
Yue, D., Li, H., Che, J., Zhang, Y., Tseng, H.-H. K., Jin, J. Q., Luh, T. M., Leprieur, E. G., Mo, M., Zheng, Q., et al. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-34 · Cited by 102 · see citing works
Sebastian, M., Passlick, B., Friccius-Quecke, H., Jäger, M., Lindhofer, H., Kanniess, F., Wiewrodt, R. G., Thiel, E., Buhl, R., & Schmittel, A. H. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0310-7 · Cited by 100 · see citing works
Zhang, M. F., Mathur, A., Zhang, Y., Xi, S., Atay, S. M., Hong, J. A., Datrice, N., Upham, T. C., Kemp, C. D., Ripley, R. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3983 · Cited by 100 · see citing works
Chittasupho, C., Lirdprapamongkol, K., Kewsuwan, P., & Sarisuta, N. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.06.020 · Cited by 97 · see citing works
Vesel, M., Rapp, J., Feller, D., Kiss, E., Járomi, L., Meggyes, M., Miskei, G., Duga, B., Smuk, G., László, T., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0537-6 · Cited by 97 · see citing works
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma
Ludwig, N., Szczepański, M. J., Głuszko, A., Szafarowski, T., Azambuja, J. H., Dolg, L., Gellrich, N., Kampmann, A., Whiteside, T. L., & Zimmerer, R. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.010 · Cited by 91 · see citing works
Amann, M., Brischwein, K., Lutterbuese, P., Parr, L., Petersen, L., Lorenczewski, G., Krinner, E., Bruckmeier, S., Lippold, S., Kischel, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2182 · Cited by 90 · see citing works
Chang, Y., Su, Y.-J., Hsiao, M., Wei, K., Lin, W., Liang, C.-J., Chen, S., & Lee, J.-L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3265 · Cited by 84 · see citing works
New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation
Aghajani, M., Mansoori, B., Mohammadi, A., Asadzadeh, Z., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28824 · Cited by 83 · see citing works
Salnikov, A. V., Bretz, N. P., Perne, C., Hazin, J., Keller, S., Fogel, M., Herr, I., Schlange, T., Moldenhauer, G., & Altevogt, P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.102 · Cited by 81 · see citing works
Elsallab, M., Levine, B. L., Wayne, A. S., & Abou-El-Enein, M. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30729-6 · Cited by 81 · see citing works
Lung cancer stem cells—characteristics, phenotype
Hardavella, G. F., George, R., & Sethi, T. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.02.01 · Cited by 77 · see citing works
Lei, H.-M., Zhang, K., Wang, C. H., Wang, Y., Zhuang, G., Lu, L., Zhang, J., Shen, Y. H., Chen, H., & Zhu, L. (2019) · Theranostics · doi:10.7150/thno.35729 · Cited by 77 · see citing works
Aldehyde-alcohol dehydrogenase forms a high-order spirosome architecture critical for its activity
Kim, G., Azmi, L., Jang, S., Jung, T., Hebert, H., Roe, A. J., Byron, O., & Song, J. (2019) · Nature Communications · doi:10.1038/s41467-019-12427-8 · Cited by 76 · see citing works
Su, Y.-J., Chang, Y.-W., Lin, W.-H., Liang, C.-L., & Lee, J.-L. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.17 · Cited by 75 · see citing works
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Das, P. K., Pillai, S., Rakib, M. A., Khanam, J. A., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09942-y · Cited by 75 · see citing works
Dong, H.-J., Jang, G.-B., Lee, H., Park, S.-R., Kim, J., Nam, J., & Hong, I. (2016) · Scientific Reports · doi:10.1038/srep22966 · Cited by 74 · see citing works
Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery
Luo, Y., Wang, X., Du, D., & Lin, Y. (2015) · Biomaterials Science · doi:10.1039/c5bm00067j · Cited by 67 · see citing works
Amann, M., d’Argouges, S., Lorenczewski, G., Brischwein, K., Kischel, R., Lutterbuese, R., Mangold, S., Rau, D., Volkland, J., Pflanz, S., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181a1c097 · Cited by 63 · see citing works
Role of Hedgehog Signaling in Vasculature Development, Differentiation, and Maintenance
Chapouly, C., Guimbal, S., Hollier, P.-L., & Renault, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123076 · Cited by 63 · see citing works
Szczepny, A., Rogers, S., Jayasekara, W. S. N., Park, K., McCloy, R. A., Cochrane, C. R., Ganju, V., Cooper, W. A., Sage, J., Peacock, C. D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.173 · Cited by 59 · see citing works
Wnt signaling as potential therapeutic target in lung cancer
Yang, J., Chen, J., He, J., Li, J., Shi, J., Cho, W. C. S., & Liu, X. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1154945 · Cited by 58 · see citing works
Roudi, R., Madjd, Z., Korourian, A., Mehrazma, M., Molanae, S., Sabet, M. N., & Shariftabrizi, A. (2014) · Cancer Biomarkers · doi:10.3233/cbm-140424 · Cited by 57 · see citing works
Koren, A., Rijavec, M., Kern, I., Sodja, E., Korošec, P., & Čufer, T. (2015) · Stem Cells International · doi:10.1155/2016/9714315 · Cited by 56 · see citing works
Adini, A., Adini, I., Ghosh, K., Benny, O., Pravda, E. A., Hu, R., Luyindula, D., & D’Amato, R. J. (2012) · Angiogenesis · doi:10.1007/s10456-012-9323-8 · Cited by 55 · see citing works
Liu, J., Mao, Z., Huang, J., Xie, S., Liu, T., & Mao, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.164 · Cited by 55 · see citing works
Roy, S., Lǚ, K., Nayak, M. K., Bhuniya, A., Ghosh, T., Kundu, S., Ghosh, S., Baral, R., Dasgupta, P., & Basu, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.748970 · Cited by 55 · see citing works
Schlereth, B., Kleindienst, P., Fichtner, I., Lorenczewski, G., Brischwein, K., Lippold, S., da Silva, A., Locher, M., Kischel, R., Lutterbüse, R., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0082-x · Cited by 54 · see citing works
Satar, N. A., Fakiruddin, K. S., Lim, M. N., Mok, P. L., Zakaria, N., Fakharuzi, N. A., Rahman, A. Z. A., Zakaria, Z., Yahaya, B. H., & Baharuddin, P. (2018) · Oncology Reports · doi:10.3892/or.2018.6461 · Cited by 53 · see citing works
Hayashi, Y., Caboni, L., Das, D., Yumoto, F., Clayton, T., Deller, M. C., Nguyen, P. T., Farr, C. L., Chiu, H., Miller, M. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502855112 · Cited by 52 · see citing works
de Aberasturi, A. L., Redrado, M., Villalba-Esparza, M., Larzábal, L., Pajares, M. J., Garcia, J., Evans, S. R., García-Ros, D., Bodegas, M. E., López, L., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.012 · Cited by 48 · see citing works
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
Fukazawa, T., Guo, M., Ishida, N., Yamatsuji, T., Takaoka, M., Yokota, E., Haisa, M., Miyake, N., Ikeda, T., Okui, T., et al. (2016) · Scientific Reports · doi:10.1038/srep20113 · Cited by 47 · see citing works
CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
Tu, Z., Xie, S., Xiong, M., Liu, Y., Yang, X., Tembo, K. M., Huang, J., Hu, W., Huang, X., Pan, S., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3812 · Cited by 47 · see citing works
Yang, J., Zhang, K., Wu, J. H., Shi, J., Xue, J., Li, J., Chen, J., Zhu, Y., Wei, J., He, J., et al. (2016) · Stem Cells International · doi:10.1155/2016/1690896 · Cited by 46 · see citing works
Self-citationSuda, K., Murakami, I., Yu, H., Kim, J., Tan, A. C., Mizuuchi, H., Rozeboom, L. M., Ellison, K. E., Rivard, C. J., Mitsudomi, T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1279 · Cited by 46 · see citing works
Liu, S., Cheng, K., Zhang, H., Kong, R., Wang, S., Mao, C., & Liu, S. (2020) · Advanced Science · doi:10.1002/advs.201903035 · Cited by 46 · see citing works
Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting
Ma, J., Zhuang, H., Zhuang, Z., Lu, Y., Xia, R., Gan, L., & Wu, Y. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1394874 · Cited by 45 · see citing works
Self-citationKumar, B., Adebayo, A. K., Prasad, M. S., Capitano, M. L., Wang, R., Bhat‐Nakshatri, P., Anjanappa, M., Simpson, E. R., Chen, D., Liu, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh3375 · Cited by 44 · see citing works
MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer
Zhou, N., Wang, H., Liu, H., Xue, H., Feng, L., Meng, X.-T., Liang, A., Zhao, Z., Liu, Y.-J., & Qian, H. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0263-1 · Cited by 43 · see citing works
Yin, J., Zhang, H., Wu, X., Zhang, Y., Li, J., Shen, J., Zhao, Y., Xiao, Z., Lu, L., Huang, C.-L., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4562 · Cited by 43 · see citing works
The viable circulating tumor cells with cancer stem cells feature, where is the way out?
Luo, Y., Cheng, J. Q., Feng, X., He, S., Wang, Y., & Huang, Q. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0685-7 · Cited by 42 · see citing works
Casagrande, N., Borghese, C., Agostini, F., Durante, C., Mazzucato, M., Colombatti, A., & Aldinucci, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063019 · Cited by 41 · see citing works
Quan, Y. H., Kim, B., Park, J., Choi, Y., Choi, Y. H., & Kim, H. K. (2014) · Experimental Lung Research · doi:10.3109/01902148.2014.905656 · Cited by 40 · see citing works
Amann, M., Friedrich, M., Lutterbuese, P., Vieser, E., Lorenczewski, G., Petersen, L., Brischwein, K., Kufer, P., Kischel, R., Baeuerle, P. A., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0529-y · Cited by 40 · see citing works
Yang, W., Song, M.-J., Park, E. Y., Lee, J.-J., Park, J., Park, K., Park, J. H., & Kim, H. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0191-x · Cited by 40 · see citing works
Alamgeer, M., Watkins, D. N., Banakh, I., Kumar, B., Gough, D. J., Markman, B., & Ganju, V. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0555-8 · Cited by 40 · see citing works
Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
Huang, X., Huang, J., Leng, D., Yang, S., Qi, Y., Sun, J., & Hu, J. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1230-4 · Cited by 38 · see citing works
Chomet, M., Schreurs, M., Nguyen, M. T. L., Howng, B., Villanueva, R., Krimm, M., Vasiljeva, O. S., van Dongen, G. A. M. S., & Vugts, D. J. (2020) · Theranostics · doi:10.7150/thno.44334 · Cited by 38 · see citing works
An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein
Mehravar, M., Ghaemimanesh, F., & Poursani, E. M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10098-3 · Cited by 38 · see citing works
Zhang, X., Lou, Y., Wang, H., Zheng, X., Dong, Q., Sun, J., & Han, B. (2015) · Medical Oncology · doi:10.1007/s12032-014-0462-1 · Cited by 37 · see citing works
Masciale, V., Grisendi, G., Banchelli, F., D’Amico, R., Maiorana, A., Sighinolfi, P., Stefani, A., Morandi, U., Dominici, M., & Aramini, B. (2020) · Oncotarget · doi:10.18632/oncotarget.27568 · Cited by 34 · see citing works
Notch1 phenotype and clinical stage progression in non-small cell lung cancer
Nguyen, D., Rubinstein, L., Takebe, N., Miele, L., Tomaszewski, J. E., Ivy, P. S., Doroshow, J. H., & Yang, S. X. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0104-2 · Cited by 27 · see citing works
Li, J., Niu, Y.-Y., Xing, Y., & Liu, F. (2017) · Bioscience Reports · doi:10.1042/bsr20171278 · Cited by 26 · see citing works
Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma
Sun, D., Yao, W., Zhang, S., Han, Y., Shen, J., Zheng, W., Lin, W., Liu, Y., Ren, L., Gu, Z., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111967 · Cited by 26 · see citing works
Chang, B., Park, M. J., Choi, S. I., In, K. H., Kim, C. H., & Lee, S. H. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s144895 · Cited by 23 · see citing works
Zhao, W., Luo, Y., Li, B., & Zhang, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5524 · Cited by 21 · see citing works
Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85
Škerlová, J., Král, V., Kachala, M., Fábry, M., Bumba, L., Svergun, D. I., Tošner, Z., Veverka, V., & Řezáčová, P. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.06.005 · Cited by 17 · see citing works
Cao, K., Pan, Y., Yu, L., Shu, X., Yang, J., Sun, L., Sun, L., Yang, Z., & Ran, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3818 · Cited by 15 · see citing works
Ouhtit, A., Thouta, R., Zayed, H., Gaur, R. L., Fernando, A., Rahman, M., & Welsh, D. A. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.33125 · Cited by 15 · see citing works
Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis
Written on behalf of the AME Lung Cancer Collaborative Group, Jin, J., Zhan, P., Qian, H., Wang, X., Katoh, M., Phan, K. H., Chung, J.-H., Lv, T., & Song, Y. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.08.08 · Cited by 14 · see citing works
Zhou, J., Sun, J., Chen, H., & Peng, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4474 · Cited by 14 · see citing works
Wang, C., Chen, S., Wu, Y., Wu, D., Wang, J., & Li, F. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.61681 · Cited by 9 · see citing works
Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
Wen, G.-M., Mou, F.-F., Hou, W., Wang, D., & Pu, X. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9865-2 · Cited by 8 · see citing works
Akamine, T., Tagawa, T., Ijichi, K., Toyokawa, G., Takamori, S., Hirai, F., Okamoto, T., Oda, Y., & Maehara, Y. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-018-07137-2 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Li, Y.-R., Fang, Y., Lyu, Z., Zhu, Y., & Yang, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04575-9 · Cited by 149 · see citing works
Intricate relationship between cancer stemness, metastasis, and drug resistance
Dakal, T. C., Bhushan, R., Xu, C., Gadi, B. R., Cameotra, S. S., Yadav, V., Maciaczyk, J., Schmidt‐Wolf, I. G. H., Kumar, A., & Sharma, A. (2024) · MedComm · doi:10.1002/mco2.710 · Cited by 71 · see citing works
Doustmihan, A., Fathi, M., Mazloomi, M., Salemi, A., Hamblin, M. R., & Jahanban‐Esfahlan, R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.029 · Cited by 67 · see citing works
Histological transformation in lung adenocarcinoma: Insights of mechanisms and therapeutic windows
Tan, N., Li, Y., Ying, J., & Chen, W. (2024) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2024-0019 · Cited by 52 · see citing works
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
Nairuz, T., Mahmud, Z., Manik, M. R. K., & Kabir, Y. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10529-x · Cited by 40 · see citing works
Clinical relevance of stem cells in lung cancer
Romeo, H. E., & Arcos, M. L. B. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i6.576 · Cited by 33 · see citing works
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Pospieszna, J., Dams‐Kozlowska, H., Udomsak, W., Murias, M., & Kucińska, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310910 · Cited by 27 · see citing works
Zaarour, R. F., Ribeiro, M., Azzarone, B. G., Kapoor, S., & Chouaı̈b, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1222575 · Cited by 24 · see citing works
Update on immune‐based therapy strategies targeting cancer stem cells
Izadpanah, A., Mohammadkhani, N., Masoudnia, M., Ghasemzad, M., Saeedian, A., Mehdizadeh, H., Poorebrahim, M., & Ebrahimi, M. (2023) · Cancer Medicine · doi:10.1002/cam4.6520 · Cited by 24 · see citing works
Comprehensive Review on the Effect of Stem Cells in Cancer Progression
Das, S., Khan, T. H., & Sarkar, D. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00053-6 · Cited by 21 · see citing works
Chen, W., Wang, F., Yu, X., Qi, J., Dong, H., Cui, B., Zhang, Q., Wu, Y., An, J., Ni, N., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02883-4 · Cited by 22 · see citing works
Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21 · see citing works
Targeting cancer stem cell pathways for lung cancer therapy
Liu, M., Wu, H., & Xu, C. S. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000912 · Cited by 20 · see citing works
Han, H., He, T., Wu, Y., He, T., & Zhou, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1441081 · Cited by 20 · see citing works
Thongsom, S., Racha, S., Petsri, K., Zin, Z., Visuttijai, K., Moriue, S., Yokoya, M., & Pithi Chanvorachote, B. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04016-6 · Cited by 19 · see citing works
Chulpanova, D. S., Rizvanov, A. A., & Solovyeva, V. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010395 · Cited by 18 · see citing works
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Hadiloo, K., Mostanadi, P., Asadzadeh, A., Taremi, S., & Esmaeilzadeh, A. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03846-3 · Cited by 17 · see citing works
Ding, K., Jiang, X., Ni, J., Zhang, C., Li, A., & Zhou, J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115043 · Cited by 17 · see citing works
Liu, H., He, R., Yang, X., Huang, B., & Liu, H. E. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092295 · Cited by 16 · see citing works
Filippi, A., Deculescu-Ioniță, T., Hudiță, A., Baldasici, O., Gălățeanu, B., & Mocanu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020631 · Cited by 17 · see citing works
Fu, Z., Huang, Z., Xu, H., Liu, Q., Li, J., Song, K., Deng, Y., Tao, Y., Zhang, H., Wang, P., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178558 · Cited by 15 · see citing works
Singh, D., Qiu, Z., Spehar, J. M., Fa, P., Thomas, H., Prasad, C. B., Cai, S., Wang, J. J., Yan, C., Zhang, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217110 · Cited by 14 · see citing works
A mathematical modeling of patient-derived lung cancer stem cells with fractional-order derivative
Özköse, F., Yılmaz, S., Şenel, M. T., Yavuz, M., Townley, S., & Sarıkaya, M. D. (2024) · Physica Scripta · doi:10.1088/1402-4896/ad80e1 · Cited by 14 · see citing works
Kevat, S., Mistry, A., Oza, N., Majmudar, M. A., Patel, N., Shah, R., Ramachandran, A. V., Chauhan, R., Haque, S., Parashar, N. C., et al. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01666-w · Cited by 14 · see citing works
Han, J. M., Kim, S. M., Kim, H. L., Cho, H. J., & Jung, H. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119437 · Cited by 14 · see citing works
Afshari, K., & Sohal, K. S. (2023) · Cancer Control · doi:10.1177/10732748231185003 · Cited by 13 · see citing works
Otani, Y., Katayama, H., Zhu, Y., Huang, R., Shigehira, T., Shien, K., Suzawa, K., Yamamoto, H., Shien, T., Toyooka, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16164 · Cited by 13 · see citing works
Pharmacological modulation of stem cells signaling pathway for therapeutic applications
Alnasser, S. M., Alrobian, A. S., Alfayez, M. S., Almutairi, O. T., Almutairi, S. S., & Alkeraidees, T. S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04438-8 · Cited by 13 · see citing works
Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids
Ponomarev, A. S., Gilazieva, Z., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070106 · Cited by 11 · see citing works
Regulation of cancer stem cells and immunotherapy of glioblastoma (Review)
Kosianova, A. A., Pak, O., & Bryukhovetskiy, I. (2023) · Biomedical Reports · doi:10.3892/br.2023.1712 · Cited by 11 · see citing works
Tsochantaridis, I., Brisimis, D., Tsifintaris, M., Anastasiadou, A., Lazos, E., Ermogenous, A., Christou, S., Antonopoulou, N., Panayiotidis, M. I., Koukourakis, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910301 · Cited by 11 · see citing works
Huang, H., Ji, B., Huang, Y., Li, S., Luo, Z., Chen, S., Li, S., Chen, Y., Bain, D. J., Sun, J., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202411334 · Cited by 11 · see citing works
Cao, Y., Yu, X., Zhou, L. F., Bo, B., Zou, Z., Jin, X., Zhao, J. T., & Zuo, X. (2025) · Advanced Materials · doi:10.1002/adma.202504363 · Cited by 10 · see citing works
Current status of molecular diagnostics for lung cancer
Имянитов, Е. Н., Преображенская, Е. В., & Орлов, С. В. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00244 · Cited by 12 · see citing works
Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective
Djamgoz, M. B. A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10809-0 · Cited by 10 · see citing works
Jiang, X., Nabil, W. N. N., Ze, Y., Dai, R., Xi, Z., & Xu, H. (2024) · Phytotherapy Research · doi:10.1002/ptr.8407 · Cited by 10 · see citing works
Chang, C., Tsai, C., Tsai, F., Chu, T. Y., Hsu, P.-C., & Kuo, C. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020123 · Cited by 10 · see citing works
Yue, P., He, Y., Zuo, R., Gong, W., Wang, Y., Chen, L., Luo, Y., Feng, Y., Gao, Y., Liu, Z., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00843-y · Cited by 9 · see citing works
Soonthonsrima, T., Putra, I. D., Phookphan, P., Zin, Z., Yokoya, M., & Pithi Chanvorachote, B. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00436 · Cited by 9 · see citing works
Chiappara, G., Vincenzo, S. D., Cascio, C., & Pace, E. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae049 · Cited by 8 · see citing works
Clinical applications of circulating biomarkers in non-small cell lung cancer
Oh, H.-J., Imam-Aliagan, A. B., Kim, Y.-B., Kim, H. J., Izaguirre, I. A., Sung, C. K., & Yim, H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1449232 · Cited by 8 · see citing works
Ibrahim, A. I., Sahyon, H. A. E., Attia, A. M. E., & El‐Shehawy, A. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-08465-6 · Cited by 10 · see citing works
Maciejewski, K., Giers, M., Oleksiewicz, U., & Czerwińska, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147841 · Cited by 8 · see citing works
Zin, Z., Racha, S., Yokoya, M., Hotta, D., Zou, H., & Pithi Chanvorachote, B. (2023) · Marine Drugs · doi:10.3390/md21120627 · Cited by 7 · see citing works
Xu, H., Zhao, G., Lin, J., Ye, Q., Xiang, J., & Yan, B. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-02945-7 · Cited by 6 · see citing works
Chen, R., Liu, Y., & Xie, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37100 · Cited by 6 · see citing works
Abbas, G., Saluja, T. S., Kumar, D., Agrawal, H., Gupta, A., Panday, G., & Singh, S. K. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113904 · Cited by 6 · see citing works
Bharadwaj, S., Mierzwicka, J. M., Vaňková, L., & Malý, P. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02410-w · Cited by 6 · see citing works
Theranostics application of tumor-initiating cell probe TiY in non-small cell lung cancer
Lee, Y., Lek, C. C. J., Gao, R., Wu, Z., Shathishwaran, S., Lee, J. H. J., Tam, W. L., Wüestefeld, T., Park, S. J., Jung, S., et al. (2023) · Theranostics · doi:10.7150/thno.79282 · Cited by 5 · see citing works
Comparison of methods for cancer stem cell detection in prognosis of early stages NSCLC
Chandouri, B., Naves, T., Yassine, M., Lea, I. A., Tricard, J., Chaunavel, A., Homayed, Z., Pannequin, J., Girard, N., Durand, S., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02839-9 · Cited by 5 · see citing works
Li, D., Cao, Y., Luo, C., Zhang, L., & Zou, Y.-B. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/0115748928265992230925053308 · Cited by 5 · see citing works
Casagrande, N., Borghese, C., Corona, G., Aldinucci, D., Altaf, M., Sulaiman, A. A. A., Isab, A. A., Ahmad, S., & Peedikakkal, A. M. P. (2023) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-023-02025-x · Cited by 5 · see citing works
Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer
Chavan, P. R., Pandey, R., Patil, B. M., Murti, K., & Kumar, N. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177494 · Cited by 7 · see citing works
tRNA-derived fragments: mechanism of gene regulation and clinical application in lung cancer
Wu, F., Yang, Q., Pan, W., Wei, M., Ma, Z., & Wang, W. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00864-z · Cited by 5 · see citing works
Alaei, E., Farahani, N., Orouei, S., Alimohammadi, M., Daneshi, S., Mousavi, T., Mahmoodieh, B., Taheriazam, A., Rahimzadeh, P., & Hashemi, M. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102028 · Cited by 4 · see citing works
PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR
Guan, A., Dai, Z., Jiang, C., Sun, J., Yang, B., Xie, B., & Chen, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167440 · Cited by 4 · see citing works
Lin, Y., Lin, Y., & Liang, C. (2023) · Cytopathology · doi:10.1111/cyt.13321 · Cited by 4 · see citing works
Discovery of Selective Aldehyde Dehydrogenase Inhibitors for the Treatment of Cancer
Kargbo, R. B. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00543 · Cited by 4 · see citing works
Zhou, Y., Zou, Y., Lv, S., Tan, D., Li, G., Fu, W., Lei, C., Lu, M., & Hu, S. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101417 · Cited by 3 · see citing works
Almarza, C., Villalobos-Nova, K., Toro, M. D. L. Á., González, M., Niechi, I., Brown‐Brown, D. A., López‐Muñoz, R., Silva-Pavez, E., Gaete‐Ramírez, B., Varas‐Godoy, M., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00551-9 · Cited by 3 · see citing works
Basak, U., Mukherjee, S., Chakraborty, S., Sa, G., Dastidar, S. G., & Das, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-93924-3 · Cited by 3 · see citing works
3D cell subculturing pillar dish for pharmacogenetic analysis and high-throughput screening
Lee, S., Hwang, H. J., Song, Y. J., Lee, D., Ku, B., Sa, J. K., & Lee, D. W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100793 · Cited by 3 · see citing works
Dehghani, M., Verdom, B. H., Rahimzadeh, F., & Abdolmaleki, P. (2025) · ADMET & DMPK · doi:10.5599/admet.3007 · Cited by 2 · see citing works
Melfi, F., Mencarelli, N., Carradori, S., Gallorini, M., Angeli, A., Poli, G., Cataldi, A., D’Agostino, I., Credico, A. D., Baldassarre, A. D., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02930 · Cited by 2 · see citing works
Neurotrophin-3 Facilitates Stemness Properties and Associates with Poor Survival in Lung Cancer
Peng, T., Wang, C.-C. C., Tang, S., Sun, G., & Sun, K. (2024) · Neuroendocrinology · doi:10.1159/000539815 · Cited by 2 · see citing works
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
Lu, J., Zhang, Y., Yan, C., Liu, J., Qi, D., Zhou, Y., Wang, Q., Yang, J., Jiang, J. T., Wu, B., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.11.019 · Cited by 2 · see citing works
Cevizlidere, B. D., Uysal, O. K., Avcı, H., Güneş, S., Sevimli, T. S., DİNÇER, M., Ekenel, E. Q., Kara, S. G., Soykan, M. N., & Sarıboyacı, A. E. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4079 · Cited by 1 · see citing works
Cancer stem cell enrichment in in vitro models: Techniques, insights, and applications
Ranjbar-Niavol, F., Barisam, M., Khosravi, A., Kashaninejad, N., Zarrabi, A., & Vosough, M. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217966 · Cited by 1 · see citing works
Reséndiz, R., González, J. M., Ortı́n, A., Asín, J., Climent, M., Borderías, L., & Heras, M. D. L. (2025) · Animals · doi:10.3390/ani15172632 · Cited by 1 · see citing works
He, Y., Acosta-Plasencia, M., Sánchez-Lorente, D., Viñolas, N., Martı́nez, D., Díaz, T., Altuna-Coy, A., Na, R., Liu, Y., Boada, M., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04342-1 · Cited by 1 · see citing works
Effects of Tumor Microenvironment on Lung Cancer Stem Cells: Bidirectional Regulatory Mechanisms
Lai, H., Luo, R., Zou, W., Liu, X., Liu, M., Liu, M., & Zhang, J. (2026) · Cancer Medicine · doi:10.1002/cam4.71868 · Cited by 1 · see citing works
Translational insights and clinical challenges of targeting cancer stem cells
Ahmed, M., Al-Haidari, A., Agarwal, S., Sun, J., Hammarlund, E. U., Rönnstrand, L., Pienta, K. J., Tatlı, Ö., & Kazi, J. U. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02887-y · Cited by 1 · see citing works
Autocrine Semaphorin 6B Signaling Is Essential for Tumorigenesis in Lung Cancer
Yamada, D., Hasegawa, T., Kawahara, K., & Maeda, T. (2025) · BPB Reports · doi:10.1248/bpbreports.8.1_18 · Cited by 1 · see citing works
Cancer stem cells detection and prognosis in early stages NSCLCPreprint
Chandouri, B., Naves, T., Yassine, M., Lea, I. A., Tricard, J., Chaunavel, A., Pannequin, J., Girard, N., Durand, S., Carré, V., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3423481/v1
Aramini, B., Masciale, V., Banchelli, F., Grisendi, G., D’Amico, R., Stella, F., Dominici, M., & Haider, K. H. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_36-1
Molecular mechanisms of tumor cell stemness modulation during formation of spheroids: a review
Ponomarev, A. S., Gilazieva, Z., Solovyova, V. V., & Rizvanov, A. A. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523070102
Sengupta, D., Banerjee, S., & Sengupta, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.05.606632
Aramini, B., Masciale, V., Banchelli, F., Grisendi, G., D’Amico, R., Stella, F., Dominici, M., & Haider, K. H. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_36
Cancer Stem Cells in Lung Cancer, a Novel Frontier
Arcos, M. L. B., & Romeo, H. E. (2024) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-74842-4_11
A Niche-Based Perspective to Stem and Cancer Stem Cells of the Lung
Boyacıoğlu, Ö., Kalali, B. D., Tongün, E., & Korkusuz, P. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_858
Horie, T., Kuwano, A., Sakamoto, T., Nakamura, Y., Yamaguchi, K., Tanida, I., Osawa, S., Yasumoto, K., & Ishigaki, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-02394-6
Gupta, D., & Kumar, M. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00056-5
Heterogeneity of ALDH1, CD133 and CD34 expression in cancer stem cells of lung adenocarcinoma
Коган, Е. А., Shchelokova, E. E., Демура, Т. А., Zharkov, N. V., Avraamova, S. T., Kovyazina, N. V., Meerovich, G. A., Meerovich, I. G., Ermakova, E. A., Kholschenkova, A. E., et al. (2025) · Russian Journal of Archive of Pathology · doi:10.17116/patol20258705136
Research Progress of Liver Metastasis Mechanisms and Predictive Indicators in Small Cell Lung Cancer
任, 雪. (2024) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2024.32027
Phytochemical Interventions in Lung Cancer: Overcoming Stem Cell-Mediated Therapy Resistance
Mondal, S., Kundu, S., & Pal, A. (2025) · doi:10.52756/lbsopf.2025.v04.012
Thongsom, S., Racha, S., Petsri, K., Zin, Z., Visuttijai, K., Moriue, S., Yokoya, M., & Pithi Chanvorachote, B. (2023) · Figshare · doi:10.6084/m9.figshare.23292135
Yamada, D., Hasegawa, T., & Maeda, T. (2025) · BPB Reports · doi:10.1248/bpbreports.8.6_216
MicroRNAs and Cancer Stem Cells: Mechanisms and Their Role in Cancer
Sennie, N. S., Pallatt, S., Shibili, P. A., Dey, A., Pathak, S., & Banerjee, A. (2026) · Advances in biochemistry in health and disease · doi:10.1007/978-3-032-08824-6_5
Sun, D., Zhang, L., Han, T., Wu, Q., Zhang, P., & Wang, C. (2026) · Nature Genetics · doi:10.1038/s41588-026-02610-1
Unmasking biomarkers in small cell lung cancer: implication for precision oncology
Parganiha, D., Joshi, M., Sankarasubramanian, S., Pandit, S. V., Nagaraj, H., & Perumal, N. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1842511
Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung Cancer
Sen, T., Gobbini, É., Mustafayev, K., Spiegelman, L. S., Akkoc-Mustafayev, F. N., Hirsch, F. R., Alahmadi, A. A., & Ahluwalia, M. S. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-5968
Kharagezov, D. A., Antonyan, A. A., Ульянова, Е. П., Сагакянц, А. Б., Златник, Е. Ю., Vitkovskaya, V. N., Артушевич, А. Э., Milakin, A. G., Айрапетова, Т. Г., Статешный, О. Н., et al. (2026) · Современные проблемы науки и образования · doi:10.17513/spno.34679
Chen, W., Li, P., Zhang, H., Sheng, Y., Yang, G., Hu, J., & Yu, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903250
Zaarour, R. F., Azakir, B., Mahmood, A. S., Nizami, Z. N., Nawafleh, H. H., Elsayed, Y., & Chouaı̈b, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0358943
Angelicola, S., Frascino, M., Chillico, I. C., Michel, P. L. S., Pistone, D., Semprini, M. S., Pittino, O. M., Ardizzoni, A., Alessio, N. L., Agustoni, F., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1945729
Patel, R., Dixit, N., Shah, K., Rawal, R., & Patel, S. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00776-4
BindingDB (2024) · UC San Diego · doi:10.7270/q2n30245
- Authors
- Zheng, Y., Wang, L., Yin, L., Yao, Z., Tong, R., Xue, J., & Lu, Y.
- Affiliations
- Sichuan University (CN)
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2022-05-26
- Volume
- 12
- Pages
- 873994-873994
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC9204354
- OpenAlex
- W4281871473
- Cited by
- 97
- References
- 116
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 28 · 2023: 31 · 2022: 2
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- West China Hospital, Sichuan University
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Keywords
- lung cancer, cancer stem cells, stem cell markers, therapeutic target, CD44, CD133, EGFR, TAP1, aldehyde dehydrogenase, Nanog, Oct4, Notch signaling, Hedgehog signaling, Wnt signaling, chemoresistance, CAR T-cell therapy, nanoparticle drug delivery, antibody-drug conjugates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
